학술논문
Metabolic syndrome and abdominal fat are associated with inflammation, but not with clinical outcomes, in peritoneal dialysis patients
Document Type
Report
Author
Source
Cardiovascular Diabetology. June 8, 2013, Vol. 12 Issue 1
Subject
Language
English
Abstract
Author(s): Jenq-Wen Huang[sup.1] , Chung-Yi Yang[sup.2] , Hon-Yen Wu[sup.1,4] , Kao-Lang Liu[sup.2] , Chi-Ting Su[sup.5] , Cho-Kai Wu[sup.1] , Jen-Kuang Lee[sup.8] , Chih-Kang Chiang[sup.1,3] , Hui-Teng Cheng[sup.6] , Yu-Chung Lien[sup.7] [...]
Background In the general population, metabolic syndrome (MetS) is correlated with visceral fat and a risk factor for cardiovascular disease (CVD); however, little is known about the significance of abdominal fat and its association with inflammation and medication use in peritoneal dialysis (PD) patients. We investigated the relationship of visceral fat area (VFA) with C-reactive protein (CRP) levels and medication use in PD patients and followed their clinical outcomes. Methods In a prospective study from February 2009 to February 2012, we assessed diabetes mellitus (DM) status, clinical and PD-associated characteristics, medication use, CRP levels, components of MetS, and VFA in 183 PD patients. These patients were categorized into 3 groups based on MetS and DM status: non-MetS (group 1, n = 73), MetS (group 2, n = 65), and DM (group 3, n = 45). VFA was evaluated by computed tomography (CT) and corrected for body mass index (BMI). Results Patients in group 1 had smaller VFAs than patients in groups 2 and 3 (3.2 [+ or -] 1.8, 4.6 [+ or -] 1.9, and 4.9 [+ or -] 2.0 cm.sup.2/[kg/m.sup.2], respectively, P < 0.05) and lower CRP levels (0.97 [+ or -] 2.31, 1.27 [+ or -] 2.57, and 1.11 [+ or -] 1.35 mg/dL, respectively, P < 0.05). VFA increased with the number of criteria met for MetS. After adjusting for age, body weight, and sex, CRP and albumin levels functioned as independent positive predictors of VFA; on other hand, the use of renin-angiotensin system blockers was inversely correlated with VFA in PD patients without DM. In the survival analysis, DM patients (group 3) had the poorest survival among the 3 groups, but no significant differences were found between groups 1 and 2. Conclusion This study showed that VFA and MetS are associated with CRP levels but cannot predict survival in PD patients without DM. The complex relationship of nutritional parameters to VFA and MetS may explain these results. The type of antihypertensive medication used was also associated with the VFA. The mechanisms behind these findings warrant further investigation. Keywords: Abdominal fat, Atherogenic indices, Beta blocker, Renin-angiotensin system blocker, Computed tomography, Metabolic syndrome, Peritoneal dialysis
Background In the general population, metabolic syndrome (MetS) is correlated with visceral fat and a risk factor for cardiovascular disease (CVD); however, little is known about the significance of abdominal fat and its association with inflammation and medication use in peritoneal dialysis (PD) patients. We investigated the relationship of visceral fat area (VFA) with C-reactive protein (CRP) levels and medication use in PD patients and followed their clinical outcomes. Methods In a prospective study from February 2009 to February 2012, we assessed diabetes mellitus (DM) status, clinical and PD-associated characteristics, medication use, CRP levels, components of MetS, and VFA in 183 PD patients. These patients were categorized into 3 groups based on MetS and DM status: non-MetS (group 1, n = 73), MetS (group 2, n = 65), and DM (group 3, n = 45). VFA was evaluated by computed tomography (CT) and corrected for body mass index (BMI). Results Patients in group 1 had smaller VFAs than patients in groups 2 and 3 (3.2 [+ or -] 1.8, 4.6 [+ or -] 1.9, and 4.9 [+ or -] 2.0 cm.sup.2/[kg/m.sup.2], respectively, P < 0.05) and lower CRP levels (0.97 [+ or -] 2.31, 1.27 [+ or -] 2.57, and 1.11 [+ or -] 1.35 mg/dL, respectively, P < 0.05). VFA increased with the number of criteria met for MetS. After adjusting for age, body weight, and sex, CRP and albumin levels functioned as independent positive predictors of VFA; on other hand, the use of renin-angiotensin system blockers was inversely correlated with VFA in PD patients without DM. In the survival analysis, DM patients (group 3) had the poorest survival among the 3 groups, but no significant differences were found between groups 1 and 2. Conclusion This study showed that VFA and MetS are associated with CRP levels but cannot predict survival in PD patients without DM. The complex relationship of nutritional parameters to VFA and MetS may explain these results. The type of antihypertensive medication used was also associated with the VFA. The mechanisms behind these findings warrant further investigation. Keywords: Abdominal fat, Atherogenic indices, Beta blocker, Renin-angiotensin system blocker, Computed tomography, Metabolic syndrome, Peritoneal dialysis